In 2024, Danish pharmaceutical company Novo Nordisk spent more than 48 billion kroner on research and development. This corresponded to some 16.6 percent of the company's total sales. Since 2020, Novo Nordisk's R&D costs have more than tripled.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Everything on "Novo Nordisk" in one document: edited and divided into chapters, including detailed references.
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield
Vice President, Hearst Magazines
Global positioning
Key metrics
Segments
Competitors
Diabetes - a growing market
Further related statistics
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
